BRPI1007474A2 - formulação para administração por via transmucosa oral de moléculas antálgicas e/ou antiespasmódicos. - Google Patents
formulação para administração por via transmucosa oral de moléculas antálgicas e/ou antiespasmódicos.Info
- Publication number
- BRPI1007474A2 BRPI1007474A2 BRPI1007474A BRPI1007474A BRPI1007474A2 BR PI1007474 A2 BRPI1007474 A2 BR PI1007474A2 BR PI1007474 A BRPI1007474 A BR PI1007474A BR PI1007474 A BRPI1007474 A BR PI1007474A BR PI1007474 A2 BRPI1007474 A2 BR PI1007474A2
- Authority
- BR
- Brazil
- Prior art keywords
- antalgic
- formulation
- transmucosal administration
- oral transmucosal
- antispasmodic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0950145A FR2940911B1 (fr) | 2009-01-13 | 2009-01-13 | Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques |
| PCT/FR2010/050039 WO2010081984A1 (fr) | 2009-01-13 | 2010-01-12 | Formulation pour l'administration par voie trans-muqueuse buccale de molecules antalgiques et/ou anti-spasmodiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1007474A2 true BRPI1007474A2 (pt) | 2016-02-16 |
Family
ID=41051115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1007474A BRPI1007474A2 (pt) | 2009-01-13 | 2010-01-12 | formulação para administração por via transmucosa oral de moléculas antálgicas e/ou antiespasmódicos. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9532947B2 (pt) |
| EP (1) | EP2387389B1 (pt) |
| JP (1) | JP2012515154A (pt) |
| CN (1) | CN102245167A (pt) |
| BR (1) | BRPI1007474A2 (pt) |
| CA (1) | CA2749245C (pt) |
| DK (1) | DK2387389T3 (pt) |
| ES (1) | ES2586619T3 (pt) |
| FR (1) | FR2940911B1 (pt) |
| HU (1) | HUE029569T2 (pt) |
| PL (1) | PL2387389T3 (pt) |
| PT (1) | PT2387389T (pt) |
| RU (1) | RU2552345C2 (pt) |
| WO (1) | WO2010081984A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2512468B1 (en) * | 2009-12-15 | 2016-08-24 | The Hospital for Sick Children | METHOD OF TREATING SCARS AND ß-CATENIN-MEDIATED DISORDERS USING NEFOPAM COMPOUNDS |
| FR2980196B1 (fr) * | 2011-09-16 | 2013-10-04 | Univ Dauvergne Clermont I | Principe actif anticancereux issu de guiera senegalensis |
| FR3000896B1 (fr) * | 2013-01-14 | 2016-08-26 | Philippe Perovitch | Forme galenique pour l'administration de principe(s) actif(s) permettant l'induction acceleree du sommeil et/ou le traitement des troubles du sommeil |
| FR3031668A1 (fr) | 2015-01-20 | 2016-07-22 | Philippe Perovitch | Dispositif d'administration d'un principe actif par voie per-muqueuse buccale. |
| FR3053244A1 (fr) | 2016-07-01 | 2018-01-05 | Philippe Perovitch | Dispositif d'administration d'au moins un principe actif par voie per-muqueuse buccale. |
| US10736905B1 (en) | 2016-09-09 | 2020-08-11 | Shahin Fatholahi | Nefopam dosage forms and methods of treatment |
| FR3063226B1 (fr) * | 2017-02-28 | 2020-05-08 | Unither Pharmaceuticals | Formulation pharmaceutique pour l'administration par voie bucco-gingivale de paracetamol |
| US10736874B1 (en) | 2017-09-08 | 2020-08-11 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| US11446311B2 (en) | 2017-09-08 | 2022-09-20 | Shahin Fatholahi | Methods for treating pain associated with sickle cell disease |
| AU2020286220B2 (en) | 2020-01-21 | 2022-09-22 | Athena Pharmaceutiques Sas | An orally disintegrating pharmacutical composition comprising nefopam and process for preparing the same |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3093544A (en) * | 1959-12-30 | 1963-06-11 | Lafon Louis | Method of relieving pain employing 1, 3, 5-trihydroxy-benzene |
| JPH10175874A (ja) * | 1996-12-19 | 1998-06-30 | Suntory Ltd | 抗アレルギー剤 |
| DE19929197A1 (de) * | 1999-06-25 | 2000-12-28 | Novosis Pharma Ag | Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung |
| CA2514574A1 (en) * | 2003-01-30 | 2004-08-12 | Dynogen Pharmaceuticals, Inc. | Use of sodium channel modulators for treating gastrointestinal tract disorders |
| GB0330049D0 (en) * | 2003-12-24 | 2004-02-04 | Arakis Ltd | The treatment of neuropathic pain conditions |
| GB0501809D0 (en) * | 2005-01-28 | 2005-03-09 | Pharmakodex Ltd | Anti-migraine formulations |
| EP1848270B1 (en) * | 2005-02-17 | 2014-05-21 | Abbott Laboratories | Transmucosal administration of drug compositions for treating and preventing disorders in animals |
| FR2906140B1 (fr) | 2006-09-22 | 2008-12-05 | Philippe Perovitch | Forme galenique pour l'administration par voie trans-muqueuse de principes actifs |
| CN101164538B (zh) * | 2006-10-16 | 2011-12-14 | 中国医学科学院基础医学研究所 | 羧胺三唑类化合物及其盐在制备治疗疼痛性疾病和/或炎症性疾病的药物中的应用 |
| FR2910317B1 (fr) * | 2006-12-21 | 2009-02-13 | Philippe Perovitch | Forme galenique pour l'administration par voie transmuqueuse de paracetamol |
| EP2124897A4 (en) * | 2006-12-22 | 2012-05-09 | Novadel Pharma Inc | SPRAYING, ORAL, STABLE, SPRAY PREPARATIONS AND ASSOCIATED METHODS |
| FR2912654B1 (fr) * | 2007-02-19 | 2009-12-25 | Rech En Toxicologie Et Pharmac | Association medicamenteuse comprenant du phloroglucinol et du paracetamol |
| FR2918874B1 (fr) * | 2007-07-20 | 2009-10-09 | Philippe Perovitch | Dispositif de conditionnement et d'administration sub-linguale de principes actifs |
| GB0721013D0 (en) * | 2007-10-25 | 2007-12-05 | Sosei R & D Ltd | New Salts |
-
2009
- 2009-01-13 FR FR0950145A patent/FR2940911B1/fr not_active Expired - Fee Related
-
2010
- 2010-01-12 HU HUE10706700A patent/HUE029569T2/en unknown
- 2010-01-12 RU RU2011134033/15A patent/RU2552345C2/ru active
- 2010-01-12 WO PCT/FR2010/050039 patent/WO2010081984A1/fr active Application Filing
- 2010-01-12 CA CA2749245A patent/CA2749245C/en active Active
- 2010-01-12 EP EP10706700.1A patent/EP2387389B1/fr active Active
- 2010-01-12 BR BRPI1007474A patent/BRPI1007474A2/pt not_active Application Discontinuation
- 2010-01-12 JP JP2011544913A patent/JP2012515154A/ja active Pending
- 2010-01-12 PL PL10706700.1T patent/PL2387389T3/pl unknown
- 2010-01-12 PT PT107067001T patent/PT2387389T/pt unknown
- 2010-01-12 US US13/144,205 patent/US9532947B2/en active Active
- 2010-01-12 CN CN2010800035208A patent/CN102245167A/zh active Pending
- 2010-01-12 DK DK10706700.1T patent/DK2387389T3/en active
- 2010-01-12 ES ES10706700.1T patent/ES2586619T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2552345C2 (ru) | 2015-06-10 |
| CN102245167A (zh) | 2011-11-16 |
| RU2011134033A (ru) | 2013-02-20 |
| EP2387389B1 (fr) | 2016-06-08 |
| PT2387389T (pt) | 2016-09-19 |
| WO2010081984A1 (fr) | 2010-07-22 |
| CA2749245A1 (en) | 2010-07-22 |
| CA2749245C (en) | 2016-12-06 |
| PL2387389T3 (pl) | 2016-12-30 |
| FR2940911A1 (fr) | 2010-07-16 |
| JP2012515154A (ja) | 2012-07-05 |
| US9532947B2 (en) | 2017-01-03 |
| HUE029569T2 (en) | 2017-03-28 |
| DK2387389T3 (en) | 2016-09-12 |
| ES2586619T3 (es) | 2016-10-17 |
| EP2387389A1 (fr) | 2011-11-23 |
| US20110275626A1 (en) | 2011-11-10 |
| FR2940911B1 (fr) | 2012-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1007474A2 (pt) | formulação para administração por via transmucosa oral de moléculas antálgicas e/ou antiespasmódicos. | |
| BRPI1009324A2 (pt) | compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos | |
| BRPI0908021A2 (pt) | Composto, composição farmacêutica, e, usos do composto ou da composição farmacêutica | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| BRPI1009372A2 (pt) | compostos, composição farmacêutica e respectivos usos | |
| BRPI1013705A2 (pt) | compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica | |
| DK2506820T3 (da) | Integreret hændelsesmarkersystem med farmaceutisk produkt til indtagelse | |
| BRPI0910503A2 (pt) | compostos, composições farmacêuticas e respectivos usos. | |
| BRPI0910557A2 (pt) | composições farmacêuticas de paclitaxel, análogos de paclitaxel ou conjugados de paclitaxel e métodos relacionados de preparação e uso. | |
| BRPI1013640A2 (pt) | composicao farmaceutica, metodos para o tratamento e usos dos mesmos | |
| BR112012003842A2 (pt) | composição farmacêutica, método de formulação e uso da mesma | |
| DK2300472T3 (da) | Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf | |
| BR112012004525A2 (pt) | composição farmacêuticas gástrico-rententivas para liberação imediata ou prolongada de acetaminofeno | |
| BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| BRPI0919231A2 (pt) | agonista de receptor de neuropeptídeo-2, composição farmacêutica que o compreende, seu uso e método para o tratamento ou profilaxia de enfermidades | |
| BRPI1007194A2 (pt) | Composição compreendendo ácido chicórico e/ou derivados do mesmo | |
| DK2391349T3 (da) | Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater | |
| BRPI0907228A2 (pt) | Compostos de tienopiridazina, suas preparações, composições farmacêuticas e usos | |
| BRPI1007484A2 (pt) | composição farmacêutica para administração oral | |
| BRPI0921313A2 (pt) | composição farmaucêutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: PAGAR RESTAURACAO. |
|
| B08H | Application fees: decision cancelled |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2384 DE 13/09/2016. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07E | Notice of approval relating to section 229 industrial property law | ||
| B06T | Formal requirements before examination | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B09B | Decision: refusal | ||
| B09B | Decision: refusal |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |